연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
2871. Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study
Caroline Even 1, Jean-Pierre Delord 2, Katharine A Price 3, Kazuhiko Nakagawa 4, Do-Youn Oh 5, Matthew Burge 6, Hyun C Chung 7, Toshihiko Doi 8, Marwan Fakih 9, Shunji Takahashi 10, Lili Yao 11, Fan Jin 11, Kevin Norwood 11, Aaron R Hansen 12
Eur J Cancer. 2022 Aug;171:259-268. doi: 10.1016/j.ejca.2022.05.007. Epub 2022 Jun 28.
Link
2870. Tolerability and efficacy of durvalumab, either as monotherapy or in combination with tremelimumab, in patients from Asia with advanced biliary tract, esophageal, or head-and-neck cancer
Yuichiro Doki 1, Makoto Ueno 2, Chih-Hung Hsu 3, Do-Youn Oh 4, Keunchil Park 5, Noboru Yamamoto 6, Tatsuya Ioka 7, Hiroki Hara 8, Manabu Hayama 9, Masahiro Nii 9, Keiko Komuro 9, Mariko Sugimoto 9, Makoto Tahara 10
Cancer Med. 2022 Jul;11(13):2550-2560. doi: 10.1002/cam4.4593. Epub 2022 May 24.
Link
2869. Health-related quality of life in patients treated with pembrolizumab for microsatellite instability-high/mismatch repair-deficient advanced solid tumours: Results from the KEYNOTE-158 study
Michele Maio 1, Mayur M Amonkar 2, Josephine M Norquist 3, Paolo A Ascierto 4, Ludmila Manzyuk 5, Daniel Motola-Kuba 6, Nicolas Penel 7, Philippe A Cassier 8, Giovanni M Bariani 9, Ana De Jesus Acosta 10, Toshihiko Doi 11, Federico Longo 12, Wilson H Miller Jr 13, Do-Youn Oh 14, Maya Gottfried 15, Ruixue Wang 16, Kevin Norwood 17, Aurelien Marabelle 18
Eur J Cancer. 2022 Jul;169:188-197. doi: 10.1016/j.ejca.2022.03.040. Epub 2022 May 16.
Link
2868. Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16)
Bum Jun Kim # 1, Hee-Jung Jee # 2, Sun Young Rha # 3 4 5, Hye Sook Han 6 7, Min-Hee Ryu 8, Se Hoon Park 9, Jong Gwang Kim 10, Woo Kyun Bae 11, Keun-Wook Lee 12, Do-Youn Oh 13 14, Ji-Hye Byun 15, Dong Sook Kim 16, Young Ju Suh 17, Hyonggin An 18, Dae Young Zang 19
Gastric Cancer. 2022 May;25(3):609-618.
Link
2867. Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma
Steven G Waguespack 1, Alexander Drilon 2 3, Jessica J Lin 4 5, Marcia S Brose 6, Ray McDermott 7, Mohammed Almubarak 8, Jessica Bauman 9, Michela Casanova 10, Anuradha Krishnamurthy 11, Shivaani Kummar 12, Serge Leyvraz 13, Do-Youn Oh 14, Keunchil Park 15, Davendra Sohal 16, Eric Sherman 2, Ricarda Norenberg 17, Josh D Silvertown 18, Nicoletta Brega 19, David S Hong 1, Maria E Cabanillas 1
Eur J Endocrinol. 2022 Apr 29;186(6):631-643
Link
2866. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
Yoon-Koo Kang 1, Li-Tzong Chen 2, Min-Hee Ryu 1, Do-Youn Oh 3, Sang Cheul Oh 4, Hyun Cheol Chung 5, Keun-Wook Lee 6, Takeshi Omori 7, Kohei Shitara 8, Shinichi Sakuramoto 9, Ik-Joo Chung 10, Kensei Yamaguchi 11, Ken Kato 12, Sun Jin Sym 13, Shigenori Kadowaki 14, Kunihiro Tsuji 15, Jen-Shi Chen 16, Li-Yuan Bai 17, Sung-Yong Oh 18, Yasuhiro Choda 19, Hisateru Yasui 20, Kentaro Takeuchi 21, Yoshinori Hirashima 21, Shunsuke Hagihara 22, Narikazu Boku 23
Lancet Oncol. 2022 Feb;23(2):234-247.
Link
2865. Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)
M M Javle 1, D-Y Oh 2, M Ikeda 3, W-P Yong 4, K Hsu 5, B Lindmark 5, N McIntyre 5, C Firth 5
ESMO Open. 2022 Feb;7(1):100314
Link
2864. ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer
Jihee Lee # 1 2, Kyoungwha Pang # 1, Junil Kim 3, Eunji Hong 1 4, Jeeyun Lee 5, Hee Jin Cho 6 7, Jinah Park 1, Minjung Son 1 4, Sihyun Park 1, Minjung Lee 8, Akira Ooshima 1, Kyung-Soon Park 2, Han-Kwang Yang 9 10, Kyung-Min Yang 8, Seong-Jin Kim 11 12
Nat Commun. 2022 Oct 28;13(1):6274.
Link
2863. In vivo and autopsy validation of alpha-synuclein seeding activity using RT-QuIC assay in the gastrointestinal tract of patients with Parkinson's disease
Chaewon Shin 1, Jung-Youn Han 2, Seong-Ik Kim 3, Sung-Hye Park 3, Han-Kwang Yang 4, Hyuk-Joon Lee 4, Seong-Ho Kong 4, Yun-Suhk Suh 5, Han-Joon Kim 6, Young Pyo Choi 2, Beomseok Jeon 7
Parkinsonism Relat Disord. 2022 Oct;103:23-28
Link
2862. Sensitivity of Detecting Alpha-Synuclein Accumulation in the Gastrointestinal Tract and Tissue Volume Examined
Chaewon Shin 1, Seong-Ik Kim 2, Sung-Hye Park 2, Jung Hwan Shin 3, Chan Young Lee 4, Han-Kwang Yang 5, Hyuk-Joon Lee 5, Seong-Ho Kong 5, Yun-Suhk Suh 6, Han-Joon Kim 3, Beomseok Jeon 3
J Mov Disord. 2022 Sep;15(3):264-268.
Link